Showing results (141-150 of 237) with videos related to

Sort By:
Pageof 24
Leukemia Research|January 9, 2018
Therapeutic effects of tyrosine kinase inhibitors and subtypes of BCR-ABL1 transcripts in Japanese chronic myeloid leukemia patients with three-way chromosomal translocationsKoiti Inokuchi, Kazutaka Nakayama, Tetsuzo Tauchi, et al.
Clinical Case Reports|September 15, 2018
Cardiac biopsy with intracardiac echocardiographic guidance for successful diagnosis of cardiac lymphomaSeiichiro Katagiri, Daigo Akahane, Tamiko Suguro, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 30, 2003
[A cold agglutinin disease, difficult to distinguish from paroxysmal cold hemoglobinuria]Tomohisa Yokoyama, Keisuke Miyazawa, Kazuyo Sunaga, et al.
Cancer Genetics and Cytogenetics|June 2, 2006
Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndromeYuko Ishii, Hui-Hua Hsiao, Goro Sashida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 30, 2004
[Primary diffuse large B-cell lymphoma of the esophagus]Masahiko Sumi, Tomoiku Takaku, Tomotaka Iguchi, et al.
International Journal of Molecular Sciences|April 20, 2016
Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of ImatinibKazuma Ohyashiki, Tomohiro Umezu, Seiichiro Katagiri, et al.
Cancer Science|June 14, 2013
Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinibIzuru Mizoguchi, Takayuki Yoshimoto, Seiichiro Katagiri, et al.
Oncology Reports|December 19, 2001
Telomerase activity during carcinogenesis in the bronchusMasatoshi Kakihana, Naoyuki Yahata, Takashi Hirano, et al.
Plos One|March 9, 2011
Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphomaKazuma Ohyashiki, Tomohiro Umezu, Sei-Ichiro Yoshizawa, et al.
International Journal of Hematology|June 27, 2008
Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromesTakahiro Suzuki, Masao Tomonaga, Yasushi Miyazaki, et al.
Pageof 24